IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Santen Pharmaceutical Co Ltd

CUSIP: 80287P100 | 17 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Rhumbline Advisers30
0.0% of portfolio›$325
StyleTurnoverLocationFiled
Rhumbline Advisers
30$3250.0%IndexVery LowBoston, MA2026-11-10